251 related articles for article (PubMed ID: 27998883)
1. Unlocking Aspirin's Chemopreventive Activity: Role of Irreversibly Inhibiting Platelet Cyclooxygenase-1.
Lichtenberger LM; Fang D; Bick RJ; Poindexter BJ; Phan T; Bergeron AL; Pradhan S; Dial EJ; Vijayan KV
Cancer Prev Res (Phila); 2017 Feb; 10(2):142-152. PubMed ID: 27998883
[TBL] [Abstract][Full Text] [Related]
2. Are Platelets the Primary Target of Aspirin's Remarkable Anticancer Activity?
Lichtenberger LM; Vijayan KV
Cancer Res; 2019 Aug; 79(15):3820-3823. PubMed ID: 31300475
[TBL] [Abstract][Full Text] [Related]
3. Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention.
Ornelas A; Zacharias-Millward N; Menter DG; Davis JS; Lichtenberger L; Hawke D; Hawk E; Vilar E; Bhattacharya P; Millward S
Cancer Metastasis Rev; 2017 Jun; 36(2):289-303. PubMed ID: 28762014
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics of platelet responsiveness to aspirin.
Faraday N; Becker DM; Becker LC
Pharmacogenomics; 2007 Oct; 8(10):1413-25. PubMed ID: 17979514
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of the antitumoural effects of aspirin in the gastrointestinal tract.
Bruno A; Dovizio M; Tacconelli S; Patrignani P
Best Pract Res Clin Gastroenterol; 2012 Aug; 26(4):e1-e13. PubMed ID: 23199511
[TBL] [Abstract][Full Text] [Related]
6. Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells.
Guillem-Llobat P; Dovizio M; Bruno A; Ricciotti E; Cufino V; Sacco A; Grande R; Alberti S; Arena V; Cirillo M; Patrono C; FitzGerald GA; Steinhilber D; Sgambato A; Patrignani P
Oncotarget; 2016 May; 7(22):32462-77. PubMed ID: 27074574
[TBL] [Abstract][Full Text] [Related]
7. Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.
Hanson SR; Harker LA; Bjornsson TD
J Clin Invest; 1985 May; 75(5):1591-9. PubMed ID: 3923041
[TBL] [Abstract][Full Text] [Related]
8. Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer.
Dachineni R; Kumar DR; Callegari E; Kesharwani SS; Sankaranarayanan R; Seefeldt T; Tummala H; Bhat GJ
Int J Oncol; 2017 Dec; 51(6):1661-1673. PubMed ID: 29075787
[TBL] [Abstract][Full Text] [Related]
9. Systems Pharmacogenomics Finds RUNX1 Is an Aspirin-Responsive Transcription Factor Linked to Cardiovascular Disease and Colon Cancer.
Voora D; Rao AK; Jalagadugula GS; Myers R; Harris E; Ortel TL; Ginsburg GS
EBioMedicine; 2016 Sep; 11():157-164. PubMed ID: 27566955
[TBL] [Abstract][Full Text] [Related]
10. Aspirin, platelets, and cancer: The point of view of the internist.
Santilli F; Boccatonda A; Davì G
Eur J Intern Med; 2016 Oct; 34():11-20. PubMed ID: 27344083
[TBL] [Abstract][Full Text] [Related]
11. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
[TBL] [Abstract][Full Text] [Related]
12. Gallic acid, a dietary polyphenolic component, blunts the inhibition of platelet COX-1 by aspirin: preliminary in-vitro findings.
Crescente M; Cerletti C; de Gaetano G
Thromb Haemost; 2007 Jun; 97(6):1054-6. PubMed ID: 17549313
[No Abstract] [Full Text] [Related]
13. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.
Lordkipanidzé M; Pharand C; Schampaert E; Turgeon J; Palisaitis DA; Diodati JG
Eur Heart J; 2007 Jul; 28(14):1702-8. PubMed ID: 17569678
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of Colorectal Cancer Prevention by Aspirin-A Literature Review and Perspective on the Role of COX-Dependent and -Independent Pathways.
Sankaranarayanan R; Kumar DR; Altinoz MA; Bhat GJ
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33260951
[TBL] [Abstract][Full Text] [Related]
15. The Multifaceted Clinical Readouts of Platelet Inhibition by Low-Dose Aspirin.
Patrono C
J Am Coll Cardiol; 2015 Jul; 66(1):74-85. PubMed ID: 26139061
[TBL] [Abstract][Full Text] [Related]
16. Roles of platelet and endothelial cell COX-1 in hypercholesterolemia-induced microvascular dysfunction.
Tailor A; Wood KC; Wallace JL; Specian RD; Granger DN
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3636-42. PubMed ID: 17933963
[TBL] [Abstract][Full Text] [Related]
17. Mode of action of aspirin as a chemopreventive agent.
Dovizio M; Bruno A; Tacconelli S; Patrignani P
Recent Results Cancer Res; 2013; 191():39-65. PubMed ID: 22893199
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in platelet reactivity and response to low-dose aspirin therapy.
Becker DM; Segal J; Vaidya D; Yanek LR; Herrera-Galeano JE; Bray PF; Moy TF; Becker LC; Faraday N
JAMA; 2006 Mar; 295(12):1420-7. PubMed ID: 16551714
[TBL] [Abstract][Full Text] [Related]
19. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.
Kobzar G; Mardla V; Samel N
Platelets; 2011; 22(5):338-44. PubMed ID: 21557683
[TBL] [Abstract][Full Text] [Related]
20. Role of platelets in inflammation and cancer: novel therapeutic strategies.
Dovizio M; Alberti S; Guillem-Llobat P; Patrignani P
Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):118-27. PubMed ID: 24118902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
